RNDOF(RNDOF)
RNDOF
No analyst ratings available
No analyst price targets available for RNDOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $213.99B | $231.03B | $249.33B | $260.66B |
| Low | $207.77B | $220.64B | $240.01B | $250.91B |
| High | $220.96B | $240.93B | $258.80B | $270.56B |
| EBITDA Avg | $88.89B | $95.96B | $103.57B | $108.27B |
| Low | $86.30B | $91.65B | $99.69B | $104.22B |
| High | $91.78B | $100.08B | $107.50B | $112.38B |
| EBIT Avg | $46.40B | $50.09B | $54.06B | $56.52B |
| Low | $45.05B | $47.84B | $52.04B | $54.40B |
| High | $47.91B | $52.24B | $56.11B | $58.66B |
| Net Income Avg | $18.96B | $22.44B | $24.90B | $27.63B |
| Low | $18.04B | $21.35B | $23.69B | $26.28B |
| High | $19.89B | $23.54B | $26.13B | $28.99B |
| EPS Avg | $72.16 | $85.40 | $94.79 | $105.15 |
| Low | $68.65 | $81.25 | $90.18 | $100.04 |
| High | $75.72 | $89.61 | $99.47 | $110.34 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 5 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $56.35B | $50.48B | $61.62B |
| Low | $55.69B | $49.89B | $60.90B |
| High | $56.90B | $50.98B | $62.22B |
| EBITDA Avg | $23.41B | $20.97B | $25.60B |
| Low | $23.13B | $20.72B | $25.30B |
| High | $23.64B | $21.17B | $25.85B |
| EBIT Avg | $12.22B | $10.95B | $13.36B |
| Low | $12.08B | $10.82B | $13.20B |
| High | $12.34B | $11.05B | $13.49B |
| Net Income Avg | $6.13B | $2.81B | $6.06B |
| Low | $6.04B | $2.76B | $5.96B |
| High | $6.21B | $2.84B | $6.13B |
| EPS Avg | $23.35 | $10.68 | $23.05 |
| Low | $22.99 | $10.52 | $22.70 |
| High | $23.64 | $10.82 | $23.34 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |